{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:13:41Z","timestamp":1790972021157,"version":"4.1.0"},"reference-count":37,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2021.2377","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T08:30:18Z","timestamp":1629707418000},"source":"Crossref","is-referenced-by-count":15,"title":["Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after hepatitis C virus eradication"],"prefix":"10.3892","volume":"15","author":[{"given":"Toshihiro","family":"Kawaguchi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ide","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Amano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Arinaga\u2011Hino","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiichiro","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Sano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirachi","family":"Miki","sequence":"additional","affiliation":[{"name":"Chikugo City Hospital, Chikugo, Fukuoka 833\u20110041, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Ono","sequence":"additional","affiliation":[{"name":"Yame General Hospital, Yame, Fukuoka 834\u20110034, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Torimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830\u20110011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"key20210906124813_b1-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/apt.14507","article-title":"Systematic review with meta-analysis: Effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia","volume":"47","author":"Ji","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"e000207","key":"key20210906124813_b2-mco-0-0-02377","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2018-000207","article-title":"Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: A systematic review and meta-analysis","volume":"5","author":"Wei","year":"2018","journal-title":"BMJ Open Gastroenterol"},{"key":"key20210906124813_b3-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jvh.13395","article-title":"Real-world safety and effectiveness of ledipasvir\/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan","volume":"28","author":"Mizokami","year":"2021","journal-title":"J Viral Hepat"},{"key":"key20210906124813_b4-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.gastro.2018.04.008","article-title":"Incidence of hepatocellular carcinoma in patients With HCV-associated cirrhosis treated with direct-acting antiviral agents","volume":"155","author":"Calvaruso","year":"2018","journal-title":"Gastroenterology"},{"key":"key20210906124813_b5-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1002\/hep.29707","article-title":"The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"key20210906124813_b6-mco-0-0-02377","author":"Ioannou"},{"key":"key20210906124813_b7-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"key20210906124813_b8-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/00365529409096841","article-title":"Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C","volume":"29","author":"Yabu","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"key20210906124813_b9-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.27305","article-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","volume":"60","author":"Yamasaki","year":"2014","journal-title":"Hepatology"},{"key":"key20210906124813_b10-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"key20210906124813_b11-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.12659\/MSM.918784","article-title":"Fibrosis index based on 4 factors (FIB-4) predicts liver cirrhosis and hepatocellular carcinoma in chronic hepatitis C virus (HCV) patients","volume":"25","author":"Li","year":"2019","journal-title":"Med Sci Monit"},{"key":"key20210906124813_b12-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: A cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"key20210906124813_b13-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers","volume":"47","author":"Guha","year":"2008","journal-title":"Hepatology"},{"key":"key20210906124813_b14-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"key":"key20210906124813_b15-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2893.2009.01263.x","article-title":"Enhanced liver fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","volume":"18","author":"Parkes","year":"2011","journal-title":"J Viral Hepat"},{"key":"key20210906124813_b16-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10238-017-0463-4","article-title":"Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment na\u00efve chronic HCV patients","volume":"18","author":"Omran","year":"2018","journal-title":"Clin Exp Med"},{"key":"key20210906124813_b17-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1373\/clinchem.2018.289108","article-title":"Enhanced liver fibrosis score as a predictor of hepatocellular carcinoma","volume":"64","author":"Loo","year":"2018","journal-title":"Clin Chem"},{"key":"key20210906124813_b18-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jhep.2017.05.028","article-title":"Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C","volume":"67","author":"Nagata","year":"2017","journal-title":"J Hepatol"},{"key":"key20210906124813_b19-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores","volume":"157","author":"Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"key20210906124813_b20-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/hep.26442","article-title":"\u03b1-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C","volume":"58","author":"Asahina","year":"2013","journal-title":"Hepatology"},{"key":"key20210906124813_b21-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/hepr.13233","article-title":"Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus","volume":"48","author":"Yasui","year":"2018","journal-title":"Hepatol Res"},{"issue":"e111551","key":"key20210906124813_b22-mco-0-0-02377","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111551","article-title":"Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice-an exploratory case-control study","volume":"9","author":"Dvorak","year":"2014","journal-title":"PLoS One"},{"key":"key20210906124813_b23-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.26030","article-title":"Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"57","author":"Tanwar","year":"2013","journal-title":"Hepatology"},{"key":"key20210906124813_b24-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MEG.0000000000001240","article-title":"Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: Association with liver histology","volume":"31","author":"Yilmaz","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20210906124813_b25-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1440-1746.2000.02233.x","article-title":"Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus interferon study group","volume":"15","author":"McHutchison","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"key20210906124813_b26-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1572-0241.2004.04055.x","article-title":"Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and hyaluronic acid","volume":"99","author":"Leroy","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"key20210906124813_b27-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0009-8981(01)00730-6","article-title":"Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C","volume":"316","author":"Boeker","year":"2002","journal-title":"Clin Chim Acta"},{"key":"key20210906124813_b28-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/hepr.12621","article-title":"Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients","volume":"46","author":"Miyaki","year":"2016","journal-title":"Hepatol Res"},{"key":"key20210906124813_b29-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.dld.2015.09.015","article-title":"Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir","volume":"48","author":"Bernuth","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"e0195632","key":"key20210906124813_b30-mco-0-0-02377","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195632","article-title":"Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C","volume":"13","author":"Yamazaki","year":"2018","journal-title":"PLoS One"},{"issue":"63","key":"key20210906124813_b31-mco-0-0-02377","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-0973-5","article-title":"Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents","volume":"19","author":"Hsu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"key20210906124813_b32-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index","volume":"37","author":"Bachofner","year":"2017","journal-title":"Liver Int"},{"key":"key20210906124813_b33-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"issue":"267","key":"key20210906124813_b34-mco-0-0-02377","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7090267","article-title":"Fibrosis staging using direct serum biomarkers is influenced by hepatitis activity grading in hepatitis C virus infection","volume":"7","author":"Fujita","year":"2018","journal-title":"J Clin Med"},{"key":"key20210906124813_b35-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/hepr.12393","article-title":"Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy","volume":"45","author":"Hiramatsu","year":"2015","journal-title":"Hepatol Res"},{"issue":"e0194163","key":"key20210906124813_b36-mco-0-0-02377","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194163","article-title":"Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication","volume":"13","author":"Motoyama","year":"2018","journal-title":"PLoS One"},{"key":"key20210906124813_b37-mco-0-0-02377","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/hepr.12082","article-title":"Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C","volume":"43","author":"Yamaguchi","year":"2013","journal-title":"Hepatol Res"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T19:47:05Z","timestamp":1630957625000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2021.2377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,23]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2021.2377","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"article-number":"215"}}